The results of a previous report suggested that CXCR4 is expressed in a subset of patients with AML and is associated with poor prognosis, and CXCR4 expression appears to be an independent prognostic factor for reduced survival in a heterogeneous group of patients with AML (38). Here, CXCR4 is linked to acute myeloid leukemia.